Adequacy and safety of pediatric native kidney biopsy using 16- and 18-gauge needles
- PMID: 40983737
- DOI: 10.1007/s00467-025-06973-1
Adequacy and safety of pediatric native kidney biopsy using 16- and 18-gauge needles
Abstract
Background: The native kidney biopsy is an important diagnostic procedure in pediatric nephrology. Recent meta-analyses did not find the size of the needle as a risk factor for bleeding complications, but they were predominantly based on adult studies. There are few papers comparing the safety and core adequacy in pediatric native kidney biopsy.
Methods: We present a large single-center retrospective study performed in a tertiary pediatric nephrology center. Data of children who received a real-time ultrasound-guided native kidney biopsy with a 16- or an 18-gauge needle from 2018 to 2024 were analyzed.
Results: Overall, 1040 children (644 boys) were included, with a median age of 10.25 (6.6; 14.23) years. One hundred three (9.9%) patients experienced bleeding complications. Perinephric hematoma was reported in 86 (8.3%) cases, gross hematuria in 18 (1.7%), and 3 (0.3%) children required transfusion. Multivariate regression analysis revealed the needle size (OR for 16-gauge 2.06, 95% CI 1.22-3.47, p = 0.007) as a risk factor for complications in the overall cohort and in children under 12 years old. The needle size did not affect complication rates in children aged 12-18 years. Inadequate kidney cores were reported in 37 (4.5%) cases; OR for 18-gauge needles (OR 5.08, 95% CI 1.07-24.21, p = 0.041) was found.
Conclusions: Use of a 16-gauge needle reduces the risk of obtaining an inadequate core in comparison with an 18-gauge. An 18G needle has a safety advantage over a 16G needle in children younger than 12 years. A 16G needle is as safe as an 18G needle and should be used for native kidney biopsy in children older than 12 years.
Keywords: Biopsy complication; Children; Kidney biopsy adequacy; Native kidney biopsy.
© 2025. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Conflict of interest statement
Declarations. Ethics approval: This manuscript was approved by the Local Independent Ethics Committee of the National Medical Research Centre of Children’s Health 15/05/25, minutes №5. Conflict of interest: The authors declare no competing interests.
References
-
- Poggio ED, McClelland RL, Blank KN et al (2020) Systematic review and meta-analysis of native kidney biopsy complications. Clin J Am Soc Nephrol 15:1595–1602. https://doi.org/10.2215/CJN.04710420 - DOI - PubMed - PMC
-
- Varnell CD, Stone HK, Welge JA (2019) Bleeding complications after pediatric kidney biopsy. Clin J Am Soc Nephrol 14:57–65. https://doi.org/10.2215/CJN.05890518 - DOI - PubMed
-
- Zhan T, Lou A (2023) Comparison of outcomes of an 18-gauge vs 16-gauge ultrasound-guided percutaneous renal biopsy: a systematic review and meta-analysis. Ren Fail 45:2257806. https://doi.org/10.1080/0886022X.2023.2257806 - DOI - PubMed - PMC
-
- Fogo B (2015) Pediatric renal pathology. In: Avner E (ed) Pediatric nephrology, 7th edn. Springer, Berlin, pp 705–749
-
- Nammalwar BR, Vijayakumar M, Prahlad N (2006) Experience of renal biopsy in children with nephrotic syndrome. Pediatr Nephrol 21:286–288. https://doi.org/10.1007/s00467-005-2084-5 - DOI - PubMed
LinkOut - more resources
Full Text Sources
